scispace - formally typeset
A

Apollonia L.J. Uitterhoeve

Researcher at University of Amsterdam

Publications -  5
Citations -  2038

Apollonia L.J. Uitterhoeve is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Cancer & Randomized controlled trial. The author has an hindex of 5, co-authored 5 publications receiving 1803 citations.

Papers
More filters
Journal ArticleDOI

Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer

TL;DR: Concomitant radiochemotherapy, as compared with sequential radiochemicalotherapy, improved survival of patients with locally advanced NSCLC, primarily because of a better locoregional control, but at the cost of manageable increased acute esophageal toxicity.
Journal ArticleDOI

Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis.

TL;DR: Implementing matched CT-FDG-PET and adapted delineation protocol and software reduced observer variation in lung cancer delineation significantly with respect to CT only, but the remaining observer variation was still large compared with other geometric uncertainties (setup variation and organ motion).
Journal ArticleDOI

Observer variation in target volume delineation of lung cancer related to radiation oncologist–computer interaction: A ‘Big Brother’ evaluation

TL;DR: This study led to recommendations on how to improve delineation accuracy by adapting the delineation protocol and delineation software (double window with lung and mediastinum L/W settings at the same time, enforced use of coronal and sagittal views) and including FDG-PET information (lymph nodes and atelectasis).
Journal ArticleDOI

Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study. European Organization for Research and Treatment of Cancer.

TL;DR: In this article, the feasibility of concurrent chemoradiation in patients with inoperable non-small cell lung cancer (NSCLC) was studied, where 40 patients were treated with escalating doses of radiotherapy and cisplatin (cDDP).
Journal ArticleDOI

Long-term results of salvage radiotherapy for the treatment of recurrent cervical carcinoma after prior surgery

TL;DR: Salvage radiotherapy for recurrent cervical carcinoma following surgery may result in 40-50% long-term disease-free survival and an acceptable risk of severe treatment complications, even in patient with recurrences extending to the pelvic wall.